Post-marketing Surveillance (PMS) to Observe the Safety and Effectiveness of Lyrica CR Extended Release Tablets
- Conditions
- Peripheral Neuropathic Pain
- Interventions
- First Posted Date
- 2019-11-21
- Last Posted Date
- 2022-06-21
- Lead Sponsor
- Viatris Korea
- Target Recruit Count
- 600
- Registration Number
- NCT04171453
- Locations
- π°π·
Seoul National University Hospital Clinical Research Institute, Seoul, Korea, Republic of
π°π·Gyeongsang National University Changwon Hospital, Changwon, Korea, Republic of
π°π·Chonbuk National University Hospital, Jeonju, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath